Benign | Malignant (carcinoma) | ||||||||
---|---|---|---|---|---|---|---|---|---|
Case | Diagnosis | ER | DR | RI* | Case | Diagnosis | ER | DR | RI† |
Nononcocytic lesions | |||||||||
TH-01 | Goiter | 1.19 | 1.32 | 10.81 | TH-22 | Follicular | 1.83 | 2.70 | 47.52 |
TH-02 | Goiter | 2.72 | 2.25 | -17.28 | TH-23 | Follicular | 6.79 | 7.20 | 6.04 |
TH-03 | Goiter | 2.81 | 1.67 | -40.64 | TH-24 | Papillary | 0.58 | 0.68 | 17.97 |
TH-04 | Goiter | 1.09 | 0.87 | -20.41 | TH-25 | Papillary | 0.40 | 0.45 | 13.64 |
TH-05 | Goiter | 2.50 | 1.40 | -44.00 | TH-26 | Papillary | 2.01 | 2.53 | 25.82 |
TH-06 | Goiter | 0.84 | 0.72 | -14.91 | TH-27 | Papillary | 2.82 | 3.88 | 37.62 |
TH-07 | Goiter | 1.50 | 1.27 | -15.15 | TH-28 | Papillary | 2.68 | 3.00 | 12.15 |
TH-08 | Goiter | 5.53 | 4.67 | -15.66 | TH-29 | Papillary | 1.94 | 2.50 | 28.91 |
TH-09 | Goiter | 9.75 | 3.75 | -61.54 | TH-30 | Papillary | 1.43 | 1.88 | 31.92 |
TH-10 | Adenoma | 2.32 | 4.67 | 101.25 | TH-31 | Papillary | 1.36 | 1.82 | 33.97 |
TH-11 | Adenoma | 3.92 | 3.45 | -11.94 | TH-32 | Papillary | 1.49 | 1.68 | 12.73 |
TH-12 | Adenoma | 1.96 | 0.78 | -60.25 | TH-33 | Papillary | 2.18 | 3.00 | 37.50 |
TH-13 | Adenoma | 1.57 | 0.80 | -49.09 | TH-34 | Papillary | 1.24 | 1.23 | -0.81 |
TH-14 | Adenoma | 1.80 | 0.83 | -53.70 | TH-35 | Papillary | 1.38 | 1.34 | -2.89 |
TH-15 | Adenoma | 0.93 | 0.81 | -12.72 | TH-36 | Poorly differentiated | 2.62 | 4.50 | 71.76 |
TH-16 | Adenoma | 0.68 | 0.58 | -14.68 | |||||
TH-17 | Adenoma | 1.35 | 1.18 | -12.78 | |||||
TH-18 | Adenoma | 0.44 | 0.25 | -43.75 | |||||
TH-19 | Adenoma | 1.54 | 1.15 | -25.10 | |||||
TH-20 | Adenoma | 1.55 | 1.25 | -19.12 | |||||
TH-21 | Adenoma | 1.14 | 0.89 | -22.22 | |||||
Oncocytic lesions | |||||||||
TH-37 | Goiter | 3.00 | 3.25 | 8.33 | TH-48 | Papillary | 1.24 | 1.41 | 13.63 |
TH-38 | Goiter | 1.69 | 2.00 | 18.68 | TH-49 | Papillary | 2.25 | 2.36 | 5.05 |
TH-39 | Goiter | 2.12 | 3.00 | 41.67 | TH-50 | Papillary | 0.70 | 1.00 | 43.33 |
TH-40 | Goiter | 0.39 | 0.55 | 39.39 | TH-51 | Insular | 3.10 | 3.84 | 23.84 |
TH-41 | Goiter | 1.20 | 1.42 | 17.88 | |||||
TH-42 | Adenoma | 1.17 | 1.65 | 41.02 | |||||
TH-43 | Adenoma | 2.90 | 5.67 | 95.29 | |||||
TH-44 | Adenoma | 2.68 | 2.07 | -22.67 | |||||
TH-45 | Adenoma | 4.00 | 3.00 | -25.00 | |||||
TH-46 | Adenoma | 2.23 | 4.17 | 86.78 | |||||
TH-47 | Adenoma | 1.76 | 1.96 | 11.65 |
↵* For benign nononcocytic lesions, all but 2 cases showed negative RI values. The 2 RI-positive cases had negative MRP1 apical expression (−). For benign oncocytic lesions, all but 2 cases showed positive RI values. The 2 RI-negative cases had positive MRP1 apical expression (++).
↵† For malignant nononcocytic lesions, all but 2 cases showed positive RI values. The 2 RI-negative cases had positive MRP1 apical expression (++). For malignant oncocytic lesions, all cases showed positive RI values and had negative MRP1 apical expression (−).